Pfizer Inc.

08/05/2022 | Press release | Distributed by Public on 08/06/2022 00:03

Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis